Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05404009 · ClinicalTrials.gov registry record
Collecting Dietary Information From People Undergoing Cancer Treatment
A clinical trial of Receiving Allogeneic Hematopoietic Cell Transplants, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT05404009: Active study of Receiving Allogeneic Hematopoietic Cell Transplants, sponsored by Memorial Sloan Kettering Cancer Center.
NCT05404009 is a study of Receiving Allogeneic Hematopoietic Cell Transplants that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05404009, a study of Receiving Allogeneic Hematopoietic Cell Transplants, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a secure method of collecting dietary and nutritional intake information from people with cancer. The researchers will use this information to learn more about how dietary information may relate to cancer diagnosis and response to treatment, and to identify factors that may lead to higher or lower risk of cancer.
Primary Outcome
of nutritional intake data from immunotherapy patients that can be paired with the fecal and blood biospecimens already being collected under other protocols (06-107, 16-834) for the purpose of conducting studying correlations between nutrition, gut microbiome, and clinical outcomes.
Conditions Studied
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-05-31 |
| Est. Completion | 2026-05 |
What the registry record for NCT05404009 still lists
NCT05404009 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Receiving Allogeneic Hematopoietic Cell Transplants appearing as the primary indexed condition, and to 0 interventions.
NCT05404009 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05404009 about?
NCT05404009 is a clinical study titled "Collecting Dietary Information From People Undergoing Cancer Treatment". The purpose of this study is to develop a secure method of collecting dietary and nutritional intake information from people with cancer. The researchers will use this information to learn more about how dietary information may relate to cancer diagnosis and response to treatment, and to identify fa...
What is the current status of trial NCT05404009?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2022-05-31. Estimated completion is 2026-05.
What conditions does trial NCT05404009 study?
This clinical trial studies the following conditions: Receiving Allogeneic Hematopoietic Cell Transplants.
Who is sponsoring clinical trial NCT05404009?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05404009 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI